October 16, 2017 - 12:00 p.m. to 1:00 p.m.
Darryl Davis, MD
Cardiac Cell Therapy 2.0: Biomaterials, pro-survival strategies and synthetic cells
Director, Cardiac Translational Research Laboratory;
CIHR Clinician Scientist
University of Ottawa Heart Institute
Chair in Cardiac Regeneration (Tier 2) & Associate Professor, Depts of Medicine & CMM;
University of Ottawa